Clinical data | |
---|---|
Trade names | Palfium |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral, Rectal, Intravenous, Insufflation[1] |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | >75%[3] |
Protein binding | High[3] |
Metabolism | Liver, partly mediated by CYP3A4[3] |
Elimination half-life | 3.5 hours[3] |
Excretion | Urine, faeces[3] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.013 |
Chemical and physical data | |
Formula | C25H32N2O2 |
Molar mass | 392.543 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Dextromoramide[4] (Palfium, Palphium, Jetrium, Dimorlin)[5] is a powerful opioid analgesic approximately three times more potent than morphine but shorter acting.[6] It is subject to drug prohibition regimes, both internationally through UN treaties and by the criminal law of individual nations, and is usually prescribed only in the Netherlands.